# Decibel Therapeutics Inc. (DBTX)

Source: https://www.quantisnow.com/company/DBTX
Generated: 2026-11-11T17:42:26.653Z

- Ticker: DBTX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2021
- Website: decibeltx.com

## About

Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to address hearing disorders caused by single gene mutations; Gene Therapies for Hair Cell Regeneration designed to replace lost hair cells within the inner ear to address acquired hearing loss and balance disorders; and Otoprotection Therapeutic in clinical development to prevent hearing loss in cancer patients undergoing chemotherapy with cisplatin. The company's lead gene therapy product candidate is DB-OTO to provide hearing to individuals born with profound hearing loss due to mutation of the otoferlin gene. It is also developing DB-ATO, a gene therapy program designed to restore balance in patients with bilateral vestibulopathy by regenerating lost hair cells within the inner ear; and DB-020 for the prevention of cisplatin-induced hearing loss, which is in Phase 1b clinical trial. Decibel Therapeutics, Inc. has a strategic collaboration with Regeneron Pharmaceuticals, Inc. to develop gene therapies for monogenic forms of congenital hearing loss. The company was formerly known as Hearing Inc. and changed its name to Decibel Therapeutics, Inc. in April 2014. Decibel Therapeutics, Inc. was incorporated in 2013 and is headquartered in Boston, Massachusetts.

## Latest DBTX news and filings

- 2024-02-14 21:55 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Decibel Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-decibel-therapeutics-inc-amendment-5264594)
- 2023-10-10 20:56 UTC [SEC Form 15-12G filed by Decibel Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-decibel-therapeutics-inc-5013433)
- 2023-10-10 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Decibel Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-decibel-therapeutics-inc-5011232)
- 2023-09-27 20:05 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Decibel Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-decibel-therapeutics-inc-amendment-4990693)
- 2023-09-25 20:35 UTC [SEC Form 4] [SEC Form 4: Trask Anna returned 106,864 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-trask-anna-returned-106864-shares-to-the-4986697)
- 2023-09-25 20:32 UTC [SEC Form 4] [SEC Form 4: Carson William H. returned 5,000 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-carson-william-h-returned-5000-shares-to-4986677)
- 2023-09-25 20:30 UTC [SEC Form 4] [SEC Form 4: Lee John Jui-Jen returned 147,144 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-lee-john-jui-jen-returned-147144-shares-to-4986661)
- 2023-09-25 20:29 UTC [SEC Form 4] [SEC Form 4: Finger Alison Cecily returned 5,000 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-finger-alison-cecily-returned-5000-shares-to-4986651)
- 2023-09-25 20:28 UTC [SEC Form 4] [SEC Form 4: Mclaughlin Kevin F returned 5,000 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-mclaughlin-kevin-f-returned-5000-shares-to-4986637)
- 2023-09-25 20:25 UTC [SEC Form 4] [SEC Form 4: Reid Laurence returned 220,849 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-reid-laurence-returned-220849-shares-to-the-4986625)
- 2023-09-25 20:24 UTC [SEC Form 4] [SEC Form 4: Kapusta Matthew C returned 10,000 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-kapusta-matthew-c-returned-10000-shares-to-4986619)
- 2023-09-25 20:24 UTC [SEC Form 4] [SEC Form 4: Nochur Sara returned 5,000 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-nochur-sara-returned-5000-shares-to-the-4986616)
- 2023-09-25 13:09 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Decibel Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-decibel-therapeutics-inc-4985849)
- 2023-09-25 13:06 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Decibel Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-decibel-therapeutics-inc-4985840)
- 2023-09-25 13:03 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Decibel Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-decibel-therapeutics-inc-4985826)
- 2023-09-25 13:00 UTC [SEC Form POS AM filed by Decibel Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-decibel-therapeutics-inc-4985810)
- 2023-09-25 12:56 UTC [SEC Form 8-K] [Decibel Therapeutics Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Material Modification to Rights of Security Holders, Changes in Control of Registrant](https://www.quantisnow.com/insight/decibel-therapeutics-inc-filed-sec-form-8-k-completion-of-acquisition-4985771)
- 2023-09-25 12:53 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by Decibel Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-decibel-therapeutics-inc-amendment-4985765)
- 2023-09-25 12:52 UTC [SEC Form 25-NSE filed by Decibel Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-decibel-therapeutics-inc-4985763)
- 2023-09-25 12:48 UTC [SEC Schedule TOT] [SEC Form SC TO-T/A filed by Decibel Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-to-ta-filed-by-decibel-therapeutics-inc-amendment-4985752)
- 2023-09-12 20:38 UTC [SEC Schedule TOT] [SEC Form SC TO-T/A filed by Decibel Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-to-ta-filed-by-decibel-therapeutics-inc-amendment-4967028)
- 2023-09-12 20:12 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by Decibel Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-decibel-therapeutics-inc-amendment-4966791)
- 2023-09-08 20:23 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by Decibel Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-decibel-therapeutics-inc-amendment-4961983)
- 2023-09-08 20:05 UTC [SEC Schedule TOT] [SEC Form SC TO-T/A filed by Decibel Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-to-ta-filed-by-decibel-therapeutics-inc-amendment-4961815)
- 2023-08-25 13:17 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9 filed by Decibel Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-sc-14d9-filed-by-decibel-therapeutics-inc-4938112)
- 2023-08-25 11:46 UTC [SEC Schedule TOT] [SEC Form SC TO-T filed by Decibel Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-sc-to-t-filed-by-decibel-therapeutics-inc-4937895)
- 2023-08-25 11:07 UTC [Market Chatter] [The FDA Has Granted Fast Track Designation To Decibel Therapeutics' DB-OTO, The Company's Lead Gene Therapy Product Candidate For Congenital Hearing Loss Caused By Mutations Of The Otoferlin Gene](https://www.quantisnow.com/insight/the-fda-has-granted-fast-track-designation-to-decibel-therapeutics-4937827)
- 2023-08-25 11:04 UTC [SEC Form 8-K] [Decibel Therapeutics Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/decibel-therapeutics-inc-filed-sec-form-8-k-other-events-4937821)
- 2023-08-18 21:16 UTC [SEC Schedule 13D] [SEC Form SC 13D filed by Decibel Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-sc-13d-filed-by-decibel-therapeutics-inc-4918444)
- 2023-08-13 00:17 UTC [Lifshitz Law PLLC Announces Investigations of WMC, MITT, DBTX, and CTG](https://www.quantisnow.com/insight/lifshitz-law-pllc-announces-investigations-of-wmc-mitt-dbtx-and-4887169)
- 2023-08-11 14:54 UTC [Market Insight] [Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet](https://www.quantisnow.com/insight/benzingas-stock-whisper-index-5-stocks-investors-are-secretly-monitoring-4883060)
- 2023-08-11 11:48 UTC [Market Chatter] [Decibel Therapeutics Q2 2023 Net Loss Of $18.15M Versus Loss Of $17.05M A Year Ago](https://www.quantisnow.com/insight/decibel-therapeutics-q2-2023-net-loss-of-1815m-versus-loss-4881819)
- 2023-08-11 11:45 UTC [Decibel Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Update](https://www.quantisnow.com/insight/decibel-therapeutics-reports-second-quarter-2023-financial-results-and-corporate-4881803)
- 2023-08-11 11:30 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Decibel Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-decibel-therapeutics-inc-4881735)
- 2023-08-10 15:00 UTC [Market Insight] [Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2023](https://www.quantisnow.com/insight/benzingas-top-ratings-upgrades-downgrades-for-august-10-2023-4876393)
- 2023-08-10 11:53 UTC [Market Insight] [Global Payments To Rally Around 17%? Here Are 10 Other Analyst Forecasts For Thursday](https://www.quantisnow.com/insight/global-payments-to-rally-around-17-here-are-10-other-4874550)
- 2023-08-10 09:28 UTC [Market Insight] [Baird Downgrades Decibel Therapeutics to Neutral, Lowers Price Target to $5.25](https://www.quantisnow.com/insight/baird-downgrades-decibel-therapeutics-to-neutral-lowers-price-target-to-4873551)
- 2023-08-09 20:55 UTC [SEC Form SC14D9C filed by Decibel Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-sc14d9c-filed-by-decibel-therapeutics-inc-4872277)
- 2023-08-09 20:15 UTC [SEC Form SC TO-C filed by Decibel Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-sc-to-c-filed-by-decibel-therapeutics-inc-4871364)
- 2023-08-09 19:17 UTC [Market Insight] [Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session](https://www.quantisnow.com/insight/why-cutera-shares-are-trading-lower-by-around-22-here-4870402)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/DBTX
- Earnings history: https://www.quantisnow.com/earnings/DBTX
- Dividend history: https://www.quantisnow.com/dividends/DBTX
- Insider transactions: https://www.quantisnow.com/insiders/DBTX
- Options chain: https://www.quantisnow.com/options/DBTX
- SEC 8-K filings only: https://www.quantisnow.com/company/DBTX/8-k
- RSS and alerts for DBTX: https://www.quantisnow.com/docs/rss-feeds.md